Medipharm Labs Corp (LABS) — Cash Flow Reinvestment Rate

Latest as of December 2023: 2.73x

Medipharm Labs Corp (LABS) has a Cash Flow Reinvestment Rate of 2.73x as of December 2023, reinvesting CA$4.43 Million (capex CA$119.00K plus investments CA$4.31 Million) from operating cash flow of CA$1.62 Million. Explore LABS capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

2.73x
(Capex + Investments) / Operating CF

Total Reinvested

CA$4.43 Million
Capex + Investments

Operating Cash Flow

CA$1.62 Million
CAD

Capital Expenditures

CA$119.00K
CAD

Medipharm Labs Corp Cash Flow Reinvestment Rate (2017–2017)

Historical reinvestment intensity for Medipharm Labs Corp across 1 annual periods. Also explore LABS current and non-current assets for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Medipharm Labs Corp (2017–2017)

Year-by-year capital reinvestment analysis for Medipharm Labs Corp. For live market cap and broader valuation context, see Medipharm Labs Corp (LABS) total market value.

Year Reinvestment Rate Total Reinvested (CAD) Operating CF Capex YoY Change
2017 13.22x CA$2.19 Million CA$166.00K CA$2.14 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow